Erik Danielsen
Net Worth
Last updated:
What is Erik Danielsen net worth?
The estimated net worth of Mr. Erik Danielsen is at least $3,745,000 as of 21 Dec 2018. He has received compensation worth at least $3,745,000 in Nymox Pharmaceutical Corporation.
What is the salary of Erik Danielsen?
Mr. Erik Danielsen salary is $535,000 per year as Chief Financial Officer & Controller in Nymox Pharmaceutical Corporation.
How old is Erik Danielsen?
Mr. Erik Danielsen is 62 years old, born in 1963.
What stocks does Erik Danielsen currently own?
As insider, Mr. Erik Danielsen owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Nymox Pharmaceutical Corporation (NYMX) | Chief Financial Officer & Controller | 20,900 | $0 | $0 |
What does Nymox Pharmaceutical Corporation do?
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperplasia, and Phase II clinical trials for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. In addition, it offers AlzheimAlert, a proprietary urine assay that aids physicians in the diagnosis of Alzheimer's disease, as well as researches and develops drug treatments for Alzheimer's disease. The company was founded in 1989 and is headquartered in Nassau, the Bahamas.
Erik Danielsen insider trading
Nymox Pharmaceutical key executives
Nymox Pharmaceutical Corporation executives and other stock owners filed with the SEC:
- Mr. Erik Danielsen (62) Chief Financial Officer & Controller
- Mr. Randall J. Lanham Esq., J.D. (61) Gen. Counsel, Sec., Chief Operating Officer & Director